Cartesian Therapeutics (RNAC) Retained Earnings (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Retained Earnings of -$4.6 million for Q1 2026, little changed year-over-year from -$4.6 million in Q1 2025, and down 100.65% quarter-over-quarter from $700.7 million in Q4 2025.
Cartesian Therapeutics (RNAC) Retained Earnings (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Retained Earnings for 12 consecutive years, with -$4.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings changed 0.13% year-over-year to -$4.6 million; the TTM figure through Mar 2026 stood at -$4.6 million (changed 0.13% YoY), while the FY2025 annual figure was $700.7 million, up 1.57% from the prior year.
- Retained Earnings retreated to -$4.6 million in Q1 2026 per RNAC's latest filing, from $700.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $700.7 million in Q4 2025 and bottomed at -$729.8 million in Q3 2025.
- Historically, Retained Earnings has averaged $65.6 million across 5 years, with a median of -$4.6 million in 2026.
- On a YoY basis, Retained Earnings climbed as much as 15097.54% in 2024 and fell as far as 14670.75% in 2024.
- Cartesian Therapeutics' Retained Earnings stood at $493.3 million in 2022, then sank by 100.93% to -$4.6 million in 2023, then surged by 15097.54% to $689.9 million in 2024, then rose by 1.57% to $700.7 million in 2025, then sank by 100.65% to -$4.6 million in 2026.
- Business Quant data shows RNAC's Retained Earnings at -$4.6 million in Q1 2026, $700.7 million in Q4 2025, and -$729.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | -845.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -845.80 Mn |
| Mar 31, 2026 | -4.58 Mn |
| Dec 31, 2025 | 700.71 Mn |
| Sep 30, 2025 | -729.80 Mn |
| Jun 30, 2025 | -693.90 Mn |
| Mar 31, 2025 | -4.59 Mn |
| Dec 31, 2024 | 689.89 Mn |
| Sep 30, 2024 | -681.82 Mn |
| Jun 30, 2024 | 560.77 Mn |
| Mar 31, 2024 | -671.47 Mn |
| Dec 31, 2023 | -4.60 Mn |
| Sep 30, 2023 | -4.62 Mn |
| Jun 30, 2023 | 498.02 Mn |
| Mar 31, 2023 | -4.57 Mn |
| Dec 31, 2022 | 493.31 Mn |
| Sep 30, 2022 | 490.25 Mn |
| Jun 30, 2022 | 487.01 Mn |
| Mar 31, 2022 | -4.60 Mn |
| Dec 31, 2021 | -4.57 Mn |
| Sep 30, 2021 | -442.60 Mn |